National Instruments Reports Q3 2016 Revenue of $306 Million
Since 1976, NI (
www.ni.com)
has made it possible for engineers and scientists to solve the world’s
greatest engineering challenges with powerful, flexible technology
solutions that accelerate productivity and drive rapid innovation.
Customers from a wide variety of industries – from healthcare to
automotive and from consumer electronics to particle physics – use NI’s
integrated hardware and software platform to improve the world we live
in. (NATI-F)
National Instruments, NI and
ni.com
are trademarks of National Instruments. Other product and company names
listed are trademarks or trade names of their respective companies.
|
|
National Instruments
|
Condensed Consolidated Balance Sheets
|
(in thousands)
|
|
|
|
|
|
|
|
|
|
|
September 30,
|
|
|
December 31,
|
|
|
|
2016
|
|
|
2015
|
|
|
|
|
|
|
|
Assets
|
|
|
|
|
|
|
Current assets:
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
|
$
|
300,652
|
|
|
|
$
|
251,129
|
|
Short-term investments
|
|
|
|
52,277
|
|
|
|
|
81,789
|
|
Accounts receivable, net
|
|
|
|
206,171
|
|
|
|
|
216,244
|
|
Inventories, net
|
|
|
|
196,391
|
|
|
|
|
185,197
|
|
Prepaid expenses and other current assets
|
|
|
|
55,281
|
|
|
|
|
65,381
|
|
Total current assets
|
|
|
|
810,772
|
|
|
|
|
799,740
|
|
|
|
|
|
|
|
|
Property and equipment, net
|
|
|
|
261,859
|
|
|
|
|
257,853
|
|
Goodwill
|
|
|
|
261,372
|
|
|
|
|
257,718
|
|
Intangible assets, net
|
|
|
|
110,161
|
|
|
|
|
108,196
|
|
Other long-term assets
|
|
|
|
28,729
|
|
|
|
|
30,349
|
|
Total assets
|
|
|
$
|
1,472,893
|
|
|
|
$
|
1,453,856
|
|
|
|
|
|
|
|
|
Liabilities and Stockholders' Equity
|
|
|
|
|
|
|
Current liabilities:
|
|
|
|
|
|
|
Accounts payable
|
|
|
$
|
53,192
|
|
|
|
$
|
50,970
|
|
Accrued compensation
|
|
|
|
31,615
|
|
|
|
|
27,956
|
|
Deferred revenue - current
|
|
|
|
113,645
|
|
|
|
|
112,283
|
|
Accrued expenses and other liabilities
|
|
|
|
23,940
|
|
|
|
|
11,756
|
|
Other taxes payable
|
|
|
|
33,461
|
|
|
|
|
37,250
|
|
Total current liabilities
|
|
|
|
255,853
|
|
|
|
|
240,215
|
|
|
|
|
|
|
|
|
Long-term debt
|
|
|
|
25,000
|
|
|
|
|
37,000
|
|
Deferred income taxes
|
|
|
|
37,787
|
|
|
|
|
44,673
|
|
Liability for uncertain tax positions
|
|
|
|
10,037
|
|
|
|
|
11,974
|
|
Deferred revenue - long-term
|
|
|
|
28,148
|
|
|
|
|
27,708
|
|
Other long-term liabilities
|
|
|
|
8,657
|
|
|
|
|
10,565
|
|
Total liabilities
|
|
|
|
365,482
|
|
|
|
|
372,135
|
|
|
|
|
|
|
|
|
Stockholders' equity:
|
|
|
|
|
|
|
Preferred stock
|
|
|
|
-
|
|
|
|
|
-
|
|
Common stock
|
|
|
|
1,289
|
|
|
|
|
1,275
|
|
Additional paid-in capital
|
|
|
|
758,411
|
|
|
|
|
717,705
|
|
Retained earnings
|
|
|
|
372,893
|
|
|
|
|
400,831
|
|
Accumulated other comprehensive loss
|
|
|
|
(25,182
|
)
|
|
|
|
(38,090
|
)
|
Total stockholders' equity
|
|
|
|
1,107,411
|
|
|
|
|
1,081,721
|
|
Total liabilities and stockholders' equity
|
|
|
$
|
1,472,893
|
|
|
|
$
|
1,453,856
|
|
|
|
|
|
|
|
|
|
|
|
|
|
National Instruments
|
Condensed Consolidated Statements of Income
|
(in thousands, except per share data, unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
Nine Months Ended
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
2016
|
|
|
2015
|
|
|
|
2016
|
|
|
2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Product
|
|
|
$
|
278,521
|
|
|
|
$
|
271,683
|
|
|
|
$
|
816,486
|
|
|
|
$
|
807,064
|
|
Software maintenance
|
|
|
|
27,843
|
|
|
|
|
28,129
|
|
|
|
|
83,161
|
|
|
|
|
84,053
|
|
Total net sales
|
|
|
|
306,364
|
|
|
|
|
299,812
|
|
|
|
|
899,647
|
|
|
|
|
891,117
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of sales:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Product
|
|
|
|
74,734
|
|
|
|
|
75,144
|
|
|
|
|
225,261
|
|
|
|
|
225,646
|
|
Software maintenance
|
|
|
|
1,998
|
|
|
|
|
2,022
|
|
|
|
|
5,126
|
|
|
|
|
4,531
|
|
Total cost of sales
|
|
|
|
76,732
|
|
|
|
|
77,166
|
|
|
|
|
230,387
|
|
|
|
|
230,177
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
|
229,632
|
|
|
|
|
222,646
|
|
|
|
|
669,260
|
|
|
|
|
660,940
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales and marketing
|
|
|
|
116,662
|
|
|
|
|
114,507
|
|
|
|
|
346,230
|
|
|
|
|
335,916
|
|
Research and development
|
|
|
|
59,066
|
|
|
|
|
52,533
|
|
|
|
|
178,244
|
|
|
|
|
168,462
|
|
General and administrative
|
|
|
|
24,537
|
|
|
|
|
23,255
|
|
|
|
|
74,308
|
|
|
|
|
69,391
|
|
Total operating expenses
|
|
|
|
200,265
|
|
|
|
|
190,295
|
|
|
|
|
598,782
|
|
|
|
|
573,769
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
|
|
29,367
|
|
|
|
|
32,351
|
|
|
|
|
70,478
|
|
|
|
|
87,171
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other income (expense):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income
|
|
|
|
276
|
|
|
|
|
396
|
|
|
|
|
787
|
|
|
|
|
1,089
|
|
Net foreign exchange (loss) gain
|
|
|
|
(760
|
)
|
|
|
|
286
|
|
|
|
|
(1,471
|
)
|
|
|
|
(1,965
|
)
|
Other (expense) income, net
|
|
|
|
301
|
|
|
|
|
133
|
|
|
|
|
(2,052
|
)
|
|
|
|
787
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes
|
|
|
|
29,184
|
|
|
|
|
33,166
|
|
|
|
|
67,742
|
|
|
|
|
87,082
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income taxes
|
|
|
|
4,695
|
|
|
|
|
9,988
|
|
|
|
|
14,155
|
|
|
|
|
23,958
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
$
|
24,489
|
|
|
|
$
|
23,178
|
|
|
|
$
|
53,587
|
|
|
|
$
|
63,124
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings per share
|
|
|
$
|
0.19
|
|
|
|
$
|
0.18
|
|
|
|
$
|
0.42
|
|
|
|
$
|
0.49
|
|
Diluted earnings per share
|
|
|
$
|
0.19
|
|
|
|
$
|
0.18
|
|
|
|
$
|
0.42
|
|
|
|
$
|
0.49
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding -
|
|
|
|
|
|
|
|
|
|
|
|
|
|
basic
|
|
|
|
128,815
|
|
|
|
|
127,935
|
|
|
|
|
128,233
|
|
|
|
|
128,219
|
|
diluted
|
|
|
|
129,047
|
|
|
|
|
128,229
|
|
|
|
|
128,738
|
|
|
|
|
128,856
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends declared per share
|
|
|
$
|
0.20
|
|
|
|
$
|
0.19
|
|
|
|
$
|
0.60
|
|
|
|
$
|
0.57
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
National Instruments
|
Condensed Consolidated Statements of Cash Flows
|
(in thousands, unaudited)
|
|
|
|
|
|
|
|
Nine Months Ended September 30,
|
|
|
|
2016
|
|
|
2015
|
|
|
|
|
Cash flow from operating activities:
|
|
|
|
|
|
|
Net income
|
|
|
$
|
53,587
|
|
|
|
$
|
63,124
|
|
Adjustments to reconcile net income to net cash provided by
operating activities:
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
|
55,164
|
|
|
|
|
55,157
|
|
Stock-based compensation
|
|
|
|
19,635
|
|
|
|
|
19,151
|
|
Tax expense/(benefit) expense from deferred income taxes
|
|
|
|
(7,321
|
)
|
|
|
|
(7,404
|
)
|
Tax benefit from stock option plans
|
|
|
|
(439
|
)
|
|
|
|
(944
|
)
|
Net change in operating assets and liabilities
|
|
|
|
32,454
|
|
|
|
|
(8,603
|
)
|
Net cash provided by operating activities
|
|
|
|
153,080
|
|
|
|
|
120,481
|
|
|
|
|
|
|
|
|
Cash flow from investing activities:
|
|
|
|
|
|
|
Capital expenditures
|
|
|
|
(34,408
|
)
|
|
|
|
(28,102
|
)
|
Capitalization of internally developed software
|
|
|
|
(24,048
|
)
|
|
|
|
(22,639
|
)
|
Additions to other intangibles
|
|
|
|
(1,969
|
)
|
|
|
|
(2,240
|
)
|
Acquisitions, net of cash received
|
|
|
|
(549
|
)
|
|
|
|
(28,629
|
)
|
Purchases of short-term investments
|
|
|
|
(9,054
|
)
|
|
|
|
(29,649
|
)
|
Sales and maturities of short-term investments
|
|
|
|
38,566
|
|
|
|
|
44,752
|
|
Net cash used by investing activities
|
|
|
|
(31,462
|
)
|
|
|
|
(66,507
|
)
|
|
|
|
|
|
|
|
Cash flow from financing activities:
|
|
|
|
|
|
|
Proceeds from revolving line of credit
|
|
|
|
15,000
|
|
|
|
|
42,000
|
|
Principal payments on revolving line of credit
|
|
|
|
(27,000
|
)
|
|
|
|
(17,000
|
)
|
Proceeds from issuance of common stock
|
|
|
|
22,157
|
|
|
|
|
21,252
|
|
Repurchase of common stock
|
|
|
|
(5,635
|
)
|
|
|
|
(72,559
|
)
|
Dividends paid
|
|
|
|
(77,056
|
)
|
|
|
|
(73,406
|
)
|
Tax benefit from stock option plans
|
|
|
|
439
|
|
|
|
|
944
|
|
Net cash used by financing activities
|
|
|
|
(72,095
|
)
|
|
|
|
(98,769
|
)
|
|
|
|
|
|
|
|
Net change in cash and cash equivalents
|
|
|
|
49,523
|
|
|
|
|
(44,795
|
)
|
Cash and cash equivalents at beginning of period
|
|
|
|
251,129
|
|
|
|
|
274,030
|
|
Cash and cash equivalents at end of period
|
|
|
$
|
300,652
|
|
|
|
$
|
229,235
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following tables provide details with respect to the amount
of GAAP charges related to stock-based compensation, amortization of
acquisition intangibles, acquisition related transaction costs,
restructuring charges, foreign exchange loss on acquisitions and
taxes levied on the transfer of acquired intellectual property that
were recorded in the line items indicated below (unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
Nine Months Ended
|
|
|
|
September 30,
|
|
|
|
June 30,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2016
|
|
|
2015
|
|
|
|
2016
|
|
|
2015
|
Stock-based compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of sales
|
|
|
$
|
556
|
|
|
|
$
|
499
|
|
|
|
|
$
|
1,643
|
|
|
|
$
|
1,427
|
|
Sales and marketing
|
|
|
|
2,635
|
|
|
|
|
2,854
|
|
|
|
|
|
8,422
|
|
|
|
|
8,303
|
|
Research and development
|
|
|
|
2,027
|
|
|
|
|
2,132
|
|
|
|
|
|
6,745
|
|
|
|
|
6,764
|
|
General and administrative
|
|
|
|
921
|
|
|
|
|
921
|
|
|
|
|
|
2,764
|
|
|
|
|
2,656
|
|
Provision for income taxes
|
|
|
|
(2,092
|
)
|
|
|
|
(1,933
|
)
|
|
|
|
|
(6,202
|
)
|
|
|
|
(5,420
|
)
|
Total
|
|
|
$
|
4,047
|
|
|
|
$
|
4,473
|
|
|
|
|
$
|
13,372
|
|
|
|
$
|
13,730
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of acquisition intangibles
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of sales
|
|
|
$
|
1,599
|
|
|
|
$
|
2,643
|
|
|
|
|
$
|
7,621
|
|
|
|
$
|
7,858
|
|
Sales and marketing
|
|
|
|
502
|
|
|
|
|
423
|
|
|
|
|
|
2,141
|
|
|
|
|
1,299
|
|
Research and development
|
|
|
|
276
|
|
|
|
|
322
|
|
|
|
|
|
815
|
|
|
|
|
983
|
|
Other income, net
|
|
|
|
-
|
|
|
|
|
145
|
|
|
|
|
|
-
|
|
|
|
|
448
|
|
Provision for income taxes
|
|
|
|
854
|
|
|
|
|
(1,152
|
)
|
|
|
|
|
1,312
|
|
|
|
|
(3,469
|
)
|
Total
|
|
|
$
|
3,231
|
|
|
|
$
|
2,381
|
|
|
|
|
$
|
11,889
|
|
|
|
$
|
7,119
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquisition transaction costs, restructuring charges, and other
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of sales
|
|
|
$
|
74
|
|
|
|
$
|
169
|
|
|
|
|
$
|
253
|
|
|
|
$
|
974
|
|
Sales and marketing
|
|
|
|
42
|
|
|
|
|
-
|
|
|
|
|
|
141
|
|
|
|
|
-
|
|
Research and development
|
|
|
|
236
|
|
|
|
|
-
|
|
|
|
|
|
648
|
|
|
|
|
-
|
|
General and administrative
|
|
|
|
97
|
|
|
|
|
238
|
|
|
|
|
|
317
|
|
|
|
|
442
|
|
Foreign exchange gain (loss) 1
|
|
|
|
-
|
|
|
|
|
-
|
|
|
|
|
|
94
|
|
|
|
|
-
|
|
Other income (loss), net 2
|
|
|
|
-
|
|
|
|
|
-
|
|
|
|
|
|
2,475
|
|
|
|
|
-
|
|
Provision for income taxes
|
|
|
|
(156
|
)
|
|
|
|
(59
|
)
|
|
|
|
|
(1,358
|
)
|
|
|
|
(390
|
)
|
Total
|
|
|
$
|
293
|
|
|
|
$
|
348
|
|
|
|
|
$
|
2,570
|
|
|
|
$
|
1,026
|
|
|
(1) Foreign exchange losses on acquisitions were $94 and $0 for the
nine month periods ended September 30, 2016 and 2015, respectively
|
(2) Taxes levied on the transfer of acquired intellectual property
were $2,475 and $0 for the nine month periods ended September 30,
2016 and 2015, respectively
|
|
|
National Instruments
|
Reconciliation of GAAP to Non-GAAP Measures
|
(in thousands, unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
Nine Months Ended
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
2016
|
|
|
2015
|
|
|
|
2016
|
|
|
2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of Gross Profit to Non-GAAP Gross Profit
|
|
|
|
|
|
|
|
Gross profit, as reported
|
|
|
$
|
229,632
|
|
|
|
$
|
222,646
|
|
|
|
|
$
|
669,260
|
|
|
|
$
|
660,940
|
|
Stock-based compensation
|
|
|
|
556
|
|
|
|
|
499
|
|
|
|
|
|
1,643
|
|
|
|
|
1,427
|
|
Amortization of acquisition intangibles
|
|
|
|
1,599
|
|
|
|
|
2,643
|
|
|
|
|
|
7,621
|
|
|
|
|
7,858
|
|
Acquisition transaction costs and restructuring charges
|
|
|
|
74
|
|
|
|
|
169
|
|
|
|
|
|
253
|
|
|
|
|
974
|
|
Non-GAAP gross profit
|
|
|
$
|
231,861
|
|
|
|
$
|
225,957
|
|
|
|
|
$
|
678,777
|
|
|
|
$
|
671,199
|
|
Non-GAAP gross margin
|
|
|
|
75.7
|
%
|
|
|
|
75.4
|
%
|
|
|
|
|
75.4
|
%
|
|
|
|
75.3
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of Operating Expenses to Non-GAAP Operating
Expenses
|
|
|
|
|
|
|
|
Operating expenses, as reported
|
|
|
$
|
200,265
|
|
|
|
$
|
190,295
|
|
|
|
|
$
|
598,782
|
|
|
|
$
|
573,769
|
|
Stock-based compensation
|
|
|
|
(5,583
|
)
|
|
|
|
(5,907
|
)
|
|
|
|
|
(17,931
|
)
|
|
|
|
(17,723
|
)
|
Amortization of acquisition intangibles
|
|
|
|
(778
|
)
|
|
|
|
(745
|
)
|
|
|
|
|
(2,956
|
)
|
|
|
|
(2,282
|
)
|
Acquisition transaction costs and restructuring charges
|
|
|
|
(375
|
)
|
|
|
|
(238
|
)
|
|
|
|
|
(1,106
|
)
|
|
|
|
(442
|
)
|
Non-GAAP operating expenses
|
|
|
$
|
193,529
|
|
|
|
$
|
183,405
|
|
|
|
|
$
|
576,789
|
|
|
|
$
|
553,322
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of Operating Income to Non-GAAP Operating Income
|
|
|
|
|
|
|
|
Operating income, as reported
|
|
|
$
|
29,367
|
|
|
|
$
|
32,351
|
|
|
|
|
$
|
70,478
|
|
|
|
$
|
87,171
|
|
Stock-based compensation
|
|
|
|
6,139
|
|
|
|
|
6,406
|
|
|
|
|
|
19,574
|
|
|
|
|
19,150
|
|
Amortization of acquisition intangibles
|
|
|
|
2,377
|
|
|
|
|
3,388
|
|
|
|
|
|
10,577
|
|
|
|
|
10,140
|
|
Acquisition transaction costs and restructuring charges
|
|
|
|
449
|
|
|
|
|
407
|
|
|
|
|
|
1,359
|
|
|
|
|
1,416
|
|
Non-GAAP operating income
|
|
|
$
|
38,332
|
|
|
|
$
|
42,552
|
|
|
|
|
$
|
101,988
|
|
|
|
$
|
117,877
|
|
Non-GAAP operating margin
|
|
|
|
12.5
|
%
|
|
|
|
14.2
|
%
|
|
|
|
|
11.3
|
%
|
|
|
|
13.2
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of Income before income taxes to Non-GAAP Income
before income taxes
|
|
|
|
|
|
|
|
Income before income taxes, as reported
|
|
|
$
|
29,184
|
|
|
|
$
|
33,166
|
|
|
|
|
$
|
67,742
|
|
|
|
$
|
87,082
|
|
Stock-based compensation
|
|
|
|
6,139
|
|
|
|
|
6,406
|
|
|
|
|
|
19,574
|
|
|
|
|
19,150
|
|
Amortization of acquisition intangibles
|
|
|
|
2,377
|
|
|
|
|
3,533
|
|
|
|
|
|
10,577
|
|
|
|
|
10,588
|
|
Acquisition transaction costs and restructuring charges
|
|
|
|
449
|
|
|
|
|
407
|
|
|
|
|
|
1,359
|
|
|
|
|
1,416
|
|
Foreign exchange loss on acquisitions
|
|
|
|
-
|
|
|
|
|
-
|
|
|
|
|
|
94
|
|
|
|
|
-
|
|
Taxes levied on transfer of acquired intellectual property
|
|
|
|
-
|
|
|
|
|
-
|
|
|
|
|
|
2,474
|
|
|
|
|
-
|
|
Non-GAAP income before income taxes
|
|
|
$
|
38,149
|
|
|
|
$
|
43,512
|
|
|
|
|
$
|
101,820
|
|
|
|
$
|
118,236
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of Provision for income taxes to Non-GAAP
Provision for income taxes
|
|
|
|
|
|
|
|
Provision for income taxes, as reported
|
|
|
$
|
4,695
|
|
|
|
$
|
9,988
|
|
|
|
|
$
|
14,155
|
|
|
|
$
|
23,958
|
|
Stock-based compensation
|
|
|
|
2,092
|
|
|
|
|
1,933
|
|
|
|
|
|
6,202
|
|
|
|
|
5,420
|
|
Amortization of acquisition intangibles
|
|
|
|
(854
|
)
|
|
|
|
1,152
|
|
|
|
|
|
(1,312
|
)
|
|
|
|
3,469
|
|
Acquisition transaction costs, restructuring charges, and other
|
|
|
|
156
|
|
|
|
|
59
|
|
|
|
|
|
1,358
|
|
|
|
|
390
|
|
Non-GAAP provision for income taxes
|
|
|
$
|
6,089
|
|
|
|
$
|
13,132
|
|
|
|
|
$
|
20,403
|
|
|
|
$
|
33,237
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of GAAP Net Income, Basic EPS and Diluted EPS to
Non-GAAP Net Income, Non-GAAP Basic EPS and Non-GAAP Diluted EPS
|
(in thousands, except per share data, unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
Nine Months Ended
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
2016
|
|
|
2015
|
|
|
|
2016
|
|
|
2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income, as reported
|
|
|
$
|
24,489
|
|
|
$
|
23,178
|
|
|
|
$
|
53,587
|
|
|
$
|
63,124
|
Adjustments to reconcile net income to non-GAAP net income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation, net of tax effect
|
|
|
|
4,047
|
|
|
|
4,473
|
|
|
|
|
13,372
|
|
|
|
13,730
|
Amortization of acquisition intangibles, net of tax effect
|
|
|
|
3,231
|
|
|
|
2,381
|
|
|
|
|
11,889
|
|
|
|
7,119
|
Acquisition transaction costs, restructuring, and other, net of tax
effect
|
|
|
|
293
|
|
|
|
348
|
|
|
|
|
2,570
|
|
|
|
1,026
|
Non-GAAP net income
|
|
|
$
|
32,060
|
|
|
$
|
30,380
|
|
|
|
$
|
81,418
|
|
|
$
|
84,999
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic EPS, as reported
|
|
|
$
|
0.19
|
|
|
$
|
0.18
|
|
|
|
$
|
0.42
|
|
|
$
|
0.49
|
Adjustment to reconcile basic EPS to non-GAAP basic EPS:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Impact of stock-based compensation, net of tax effect
|
|
|
|
0.03
|
|
|
|
0.04
|
|
|
|
|
0.10
|
|
|
|
0.11
|
Impact of amortization of acquisition intangibles, net of tax effect
|
|
|
|
0.03
|
|
|
|
0.02
|
|
|
|
|
0.09
|
|
|
|
0.06
|
Impact of acquisition transaction costs, restructuring, and other,
net of tax effect
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
0.02
|
|
|
|
-
|
Non-GAAP basic EPS
|
|
|
$
|
0.25
|
|
|
$
|
0.24
|
|
|
|
$
|
0.63
|
|
|
$
|
0.66
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted EPS, as reported
|
|
|
$
|
0.19
|
|
|
$
|
0.18
|
|
|
|
$
|
0.42
|
|
|
$
|
0.49
|
Adjustment to reconcile diluted EPS to non-GAAP diluted EPS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Impact of stock-based compensation, net of tax effect
|
|
|
|
0.03
|
|
|
|
0.04
|
|
|
|
|
0.10
|
|
|
|
0.11
|
Impact of amortization of acquisition intangibles, net of tax effect
|
|
|
|
0.03
|
|
|
|
0.02
|
|
|
|
|
0.09
|
|
|
|
0.06
|
Impact of acquisition transaction costs, restructuring, and other,
net of tax effect
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
0.02
|
|
|
|
-
|
Non-GAAP diluted EPS
|
|
|
$
|
0.25
|
|
|
$
|
0.24
|
|
|
|
$
|
0.63
|
|
|
$
|
0.66
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding -
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
|
128,815
|
|
|
|
127,935
|
|
|
|
|
128,233
|
|
|
|
128,219
|
Diluted
|
|
|
|
129,047
|
|
|
|
128,229
|
|
|
|
|
128,738
|
|
|
|
128,856
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
National Instruments
|
Reconciliation of Net Income to EBITDA
|
(in thousands, unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
Nine Months Ended
|
|
|
|
September 30,
|
|
|
|
September 30,
|
|
|
|
2016
|
|
|
2015
|
|
|
|
2016
|
|
|
2015
|
Net income, as reported
|
|
|
$
|
24,489
|
|
|
|
$
|
23,178
|
|
|
|
|
$
|
53,587
|
|
|
|
$
|
63,124
|
|
Adjustments to reconcile net income to EBITDA:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income
|
|
|
|
(53
|
)
|
|
|
|
(396
|
)
|
|
|
|
|
(194
|
)
|
|
|
|
(1,089
|
)
|
Tax expense
|
|
|
|
4,695
|
|
|
|
|
9,988
|
|
|
|
|
|
14,155
|
|
|
|
|
23,958
|
|
Depreciation and amortization
|
|
|
|
16,947
|
|
|
|
|
18,655
|
|
|
|
|
|
55,164
|
|
|
|
|
55,157
|
|
EBITDA
|
|
|
$
|
46,078
|
|
|
|
$
|
51,425
|
|
|
|
|
$
|
122,712
|
|
|
|
$
|
141,150
|
|
Weighted average shares outstanding - Diluted
|
|
|
|
129,047
|
|
|
|
|
128,229
|
|
|
|
|
|
128,738
|
|
|
|
|
128,856
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of GAAP to Non-GAAP EPS Guidance
|
(unaudited)
|
|
|
|
Three months ended
|
|
|
|
|
|
|
|
|
|
|
December 31, 2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Low
|
|
|
High
|
|
|
|
|
|
|
|
GAAP Fully Diluted EPS, guidance
|
|
|
$
|
0.24
|
|
|
|
$
|
0.36
|
|
|
|
|
|
|
|
|
Adjustment to reconcile diluted EPS to non-GAAP diluted EPS:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Impact of stock-based compensation, net of tax effect
|
|
|
|
0.04
|
|
|
|
|
0.04
|
|
|
|
|
|
|
|
|
Impact of amortization of acquisition intangibles and acquisition
accounting adjustments, net of tax effect
|
|
|
|
0.04
|
|
|
|
|
0.04
|
|
|
|
|
|
|
|
|
Non-GAAP diluted EPS, guidance
|
|
|
$
|
0.32
|
|
|
|
$
|
0.44
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
National Instruments
|
Reconciliation of GAAP Revenue Growth to Core Revenue Growth
|
(unaudited)
|
|
|
|
|
|
|
|
Three Months Ended,
|
|
|
|
September 30,
|
|
|
|
2016
|
YoY GAAP revenue growth, as reported
|
|
|
$
|
2
|
%
|
Effect of excluding our current largest customer
|
|
|
|
-1
|
%
|
YoY GAAP revenue growth, excluding our largest customer
|
|
|
|
1
|
%
|
Effect of excluding the impact of foreign currency exchange
|
|
|
|
3
|
%
|
YoY Core revenue growth
|
|
|
$
|
4
|
%
|
|
|
|
|
|
National Instruments
|
Reconciliation of GAAP Revenue Growth Guidance to Core Revenue
Growth Guidance
|
(unaudited)
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
December 31,
|
|
|
|
2016
|
Estimated YoY GAAP revenue growth, as reported
|
|
|
$
|
1
|
%
|
Estimated effect of excluding our current largest customer
|
|
|
|
2
|
%
|
Estimated YoY GAAP revenue growth, excluding our largest customer
|
|
|
|
3
|
%
|
Estimated effect of excluding the impact of foreign currency exchange
|
|
|
|
2
|
%
|
Estimated YoY Core revenue growth
|
|
|
$
|
5
|
%
|
|